Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

CRIS

Curis (CRIS)

Curis Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CRIS
日付受信時刻ニュースソース見出しコード企業名
2024/05/1021 : 00PR Newswire (US)Curis to Present Updated Data from the TakeAim Leukemia StudyNASDAQ:CRISCuris Inc
2024/05/0721 : 30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRISCuris Inc
2024/05/0721 : 02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRISCuris Inc
2024/05/0721 : 00PR Newswire (US)Curis Provides First Quarter 2024 Business UpdateNASDAQ:CRISCuris Inc
2024/04/3021 : 00PR Newswire (US)Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024NASDAQ:CRISCuris Inc
2024/04/0520 : 30PR Newswire (US)Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:CRISCuris Inc
2024/04/0420 : 30PR Newswire (US)Curis to Present at Upcoming Healthcare Conferences in AprilNASDAQ:CRISCuris Inc
2024/02/1306 : 16Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CRISCuris Inc
2024/02/0906 : 36Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CRISCuris Inc
2024/02/0906 : 27Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CRISCuris Inc
2024/02/0906 : 01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CRISCuris Inc
2024/02/0822 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRISCuris Inc
2024/02/0822 : 00PR Newswire (US)Curis Provides Fourth Quarter 2023 Business UpdateNASDAQ:CRISCuris Inc
2024/02/0122 : 00PR Newswire (US)Curis to Release Fourth Quarter 2023 Financial Results and Hold Conference Call on February 8, 2024NASDAQ:CRISCuris Inc
2024/01/1122 : 13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRISCuris Inc
2024/01/0522 : 00PR Newswire (US)Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:CRISCuris Inc
2023/12/2206 : 00Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:CRISCuris Inc
2023/12/1222 : 00PR Newswire (US)Curis Announces Initial Combination Study Data from its TakeAim Lymphoma StudyNASDAQ:CRISCuris Inc
2023/12/1122 : 00PR Newswire (US)Curis Presented Clinical Data from the TakeAim Leukemia Study at the 2023 ASH ConferenceNASDAQ:CRISCuris Inc
2023/12/0622 : 00PR Newswire (US)Curis Announces Three Presentations at ASHNASDAQ:CRISCuris Inc
2023/12/0522 : 00PR Newswire (US)Curis Enters into Agreement for Emavusertib / Pembrolizumab Combination Study in MelanomaNASDAQ:CRISCuris Inc
2023/11/0221 : 03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRISCuris Inc
2023/11/0221 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRISCuris Inc
2023/11/0221 : 00PR Newswire (US)Curis Provides Third Quarter 2023 Business UpdateNASDAQ:CRISCuris Inc
2023/10/2621 : 30PR Newswire (US)Curis to Release Third Quarter 2023 Financial Results and Hold Conference Call on November 2, 2023NASDAQ:CRISCuris Inc
2023/10/0621 : 56PR Newswire (US)Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:CRISCuris Inc
2023/09/2905 : 05Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:CRISCuris Inc
2023/09/2821 : 54Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRISCuris Inc
2023/09/1221 : 00PR Newswire (US)Curis Announces Date for the 2nd Symposium on IRAK4 in CancerNASDAQ:CRISCuris Inc
2023/09/0621 : 13PR Newswire (US)Curis to Present at Upcoming Healthcare Conferences in SeptemberNASDAQ:CRISCuris Inc
 Showing the most relevant articles for your search:NASDAQ:CRIS